Characteristics of Rare Inherited Retinal Dystrophies in Adaptive Optics-A Study on 53 Eyes.
Stargardt disease
adaptive optics
cone dystrophy
cone-rod dystrophy
inherited retinal diseases
inherited retinal dystrophies
photoreceptors
retinal imaging
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
25 Jul 2023
25 Jul 2023
Historique:
received:
16
05
2023
revised:
21
07
2023
accepted:
24
07
2023
medline:
12
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
Inherited retinal dystrophies (IRDs) are genetic disorders that lead to the bilateral degeneration of the retina, causing irreversible vision loss. These conditions often manifest during the first and second decades of life, and their primary symptoms can be non-specific. Diagnostic processes encompass assessments of best-corrected visual acuity, fundoscopy, optical coherence tomography, fundus autofluorescence, fluorescein angiography, electrophysiological tests, and genetic testing. This study focuses on the application of adaptive optics (AO), a non-invasive retinal examination, for the assessment of patients with IRDs. AO facilitates the high-quality, detailed observation of retinal photoreceptor structures (cones and rods) and enables the quantitative analysis of parameters such as cone density (DM), cone spacing (SM), cone regularity (REG), and Voronoi analysis (N%6). AO examinations were conducted on eyes diagnosed with Stargardt disease (STGD, N=36), cone dystrophy (CD, N=9), and cone-rod dystrophy (CRD, N=8), and on healthy eyes (N=14). There were significant differences in the DM, SM, REG, and N%6 parameters between the healthy and IRD-affected eyes (p<0.001 for DM, SM, and REG; p=0.008 for N%6). The mean DM in the CD, CRD, and STGD groups was 8900.39/mm2, 9296.32/mm2, and 16,209.66/mm2, respectively, with a significant inter-group difference (p=0.006). The mean SM in the CD, CRD, and STGD groups was 12.37 μm, 14.82 μm, and 9.65 μm, respectively, with a significant difference observed between groups (p=0.002). However, no significant difference was found in REG and N%6 among the CD, CRD, and STGD groups. Significant differences were found in SM and DM between CD and STGD (p=0.014 for SM; p=0.003 for DM) and between CRD and STGD (p=0.027 for SM; p=0.003 for DM). Our findings suggest that AO holds significant potential as an impactful diagnostic tool for IRDs.
Identifiants
pubmed: 37568834
pii: diagnostics13152472
doi: 10.3390/diagnostics13152472
pmc: PMC10417470
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Invest Ophthalmol Vis Sci. 2006 May;47(5):2080-92
pubmed: 16639019
Indian J Ophthalmol. 2022 Jul;70(7):2316-2325
pubmed: 35791112
Invest Ophthalmol Vis Sci. 2017 Jul 1;58(9):3608-3615
pubmed: 28738413
JAMA Ophthalmol. 2018 Aug 1;136(8):920-928
pubmed: 29902293
J Opt Soc Am A Opt Image Sci Vis. 1997 Nov;14(11):2884-92
pubmed: 9379246
Adv Exp Med Biol. 2010;664:333-40
pubmed: 20238033
Appl Opt. 1989 Feb 15;28(4):804-8
pubmed: 20548563
Sci Rep. 2018 May 21;8(1):7911
pubmed: 29784939
Transl Vis Sci Technol. 2016 Mar 11;5(2):6
pubmed: 26981328
Am J Ophthalmol. 2020 Aug;216:219-225
pubmed: 32222369
Biomed Opt Express. 2016 Dec 02;8(1):16-37
pubmed: 28101398
Br J Ophthalmol. 2019 Jan 24;:
pubmed: 30679166
Medicine (Baltimore). 2017 Jun;96(25):e7300
pubmed: 28640147
JAMA Ophthalmol. 2015 Oct;133(10):1198-203
pubmed: 26247787
Lasers Surg Med. 2012 Oct;44(8):603-10
pubmed: 22930575
Invest Ophthalmol Vis Sci. 2013 Aug 28;54(8):5836-47
pubmed: 23908179
Transl Vis Sci Technol. 2022 May 2;11(5):19
pubmed: 35583887
J Diabetes Res. 2019 Mar 17;2019:9548324
pubmed: 31008115
Mol Ther. 2021 Feb 3;29(2):442-463
pubmed: 33278565
Doc Ophthalmol. 2015 Jun;130(3):241-51
pubmed: 25708979
JAMA Ophthalmol. 2014 Sep;132(9):1099-104
pubmed: 24922193
Exp Eye Res. 2016 Apr;145:93-99
pubmed: 26593885
Invest Ophthalmol Vis Sci. 2013 Dec 17;54(13):8181-90
pubmed: 24265018
Clin Genet. 2013 Aug;84(2):132-41
pubmed: 23701314
Ther Adv Ophthalmol. 2022 Nov 4;14:25158414221134602
pubmed: 36388727
Stem Cell Res Ther. 2021 Aug 19;12(1):464
pubmed: 34412697
Medicina (Kaunas). 2022 Mar 31;58(4):
pubmed: 35454342
J Ophthalmol. 2021 Feb 26;2021:6642059
pubmed: 33728057
Invest Ophthalmol Vis Sci. 2019 Jul 1;60(8):3187-3196
pubmed: 31335944
Retina. 2016 Jan;36(1):119-30
pubmed: 26110599
Am J Ophthalmol. 2021 Oct;230:12-47
pubmed: 34000280
Int J Mol Sci. 2021 Feb 20;22(4):
pubmed: 33672611
Surv Ophthalmol. 1988 Nov-Dec;33(3):137-77
pubmed: 3068820
Biomed Opt Express. 2023 Feb 28;14(3):1307-1338
pubmed: 36950228
Am J Ophthalmol. 2015 Aug;160(2):301-312.e6
pubmed: 25908487
JAMA Ophthalmol. 2019 Oct 01;137(10):1134-1145
pubmed: 31369039
Orphanet J Rare Dis. 2006 Oct 11;1:40
pubmed: 17032466
JAMA Ophthalmol. 2019 Jun 1;137(6):603-609
pubmed: 30896765
Ophthalmol Retina. 2019 Oct;3(10):888-899
pubmed: 31235310
Ophthalmic Genet. 2018 Aug;39(4):500-507
pubmed: 29718797
NPJ Genom Med. 2021 Feb 19;6(1):16
pubmed: 33608557
Graefes Arch Clin Exp Ophthalmol. 2015 Nov;253(11):1985-95
pubmed: 26267750
Invest Ophthalmol Vis Sci. 2011 May 17;52(6):3281-92
pubmed: 21296825
J Hypertens. 2016 Jun;34(6):1115-22
pubmed: 27065002
Front Mol Neurosci. 2023 Jan 09;15:1068185
pubmed: 36710928
Br J Ophthalmol. 2014 Aug;98(8):1073-9
pubmed: 24729030
Biomed Opt Express. 2017 May 26;8(6):3081-3094
pubmed: 28663928
Retina. 2020 Feb;40(2):376-386
pubmed: 31972809
Eye (Lond). 2019 Nov;33(11):1683-1698
pubmed: 31164730
Br J Ophthalmol. 2017 Jan;101(1):25-30
pubmed: 27491360
Transl Vis Sci Technol. 2021 Dec 1;10(14):11
pubmed: 34904999
Clin Exp Optom. 2021 May;104(4):444-454
pubmed: 33689657
Invest Ophthalmol Vis Sci. 2013 Jan 30;54(1):898-908
pubmed: 23221069
Invest Ophthalmol Vis Sci. 2007 May;48(5):2297-303
pubmed: 17460294
Transl Vis Sci Technol. 2019 Mar 01;8(2):1
pubmed: 30834176
Ther Adv Ophthalmol. 2021 Dec 19;13:25158414211056384
pubmed: 34988368
Ophthalmology. 2012 Apr;119(4):819-26
pubmed: 22264887
Invest Ophthalmol Vis Sci. 2014 Jun 06;55(7):4244-51
pubmed: 24906859
JAMA Ophthalmol. 2017 Nov 1;135(11):1232-1241
pubmed: 29049437
Ophthalmology. 2006 Jun;113(6):1019.e1
pubmed: 16650474
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3283-91
pubmed: 17591900
Br J Ophthalmol. 2018 Jan;102(1):136-141
pubmed: 29074494
Transl Vis Sci Technol. 2019 May 08;8(3):17
pubmed: 31114717
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):1234-1243
pubmed: 30924848
Lancet. 2015 Feb 7;385(9967):509-16
pubmed: 25458728
Sensors (Basel). 2012 Dec 27;13(1):334-66
pubmed: 23271600
Biomed Opt Express. 2022 Dec 20;14(1):387-428
pubmed: 36698659
J Diabetes Res. 2017;2017:4174292
pubmed: 29238728
Prog Retin Eye Res. 2010 May;29(3):191-207
pubmed: 20096366
Br J Ophthalmol. 2021 Jun;105(6):829-837
pubmed: 32727729